Portefeuille d'ETF SCHB (NYSE) - Page 113 | MetaTrader

Afficher le graphique complet

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

REPX Riley Exploration Permian Inc 180.5961 K 6 262.0000 0.0005%

GCO Genesco Inc 180.0019 K 6 608.0000 0.0005%

HCKT Hackett Group Inc/The 179.7246 K 13.1570 K 0.0005%

BVS Bioventus Inc 179.3842 K 20.4310 K 0.0005%

DNA Ginkgo Bioworks Holdings Inc 178.7197 K 26.4770 K 0.0005%

ATNI ATN International Inc 178.6840 K 6 200.0000 0.0005%

MPLT MapLight Therapeutics Inc 178.3818 K 10.3290 K 0.0005%

GRPN Groupon Inc 177.7401 K 14.0840 K 0.0005%

NABL N-able Inc/US 176.6996 K 40.1590 K 0.0005%

NMRA Neumora Therapeutics Inc 176.0356 K 50.4400 K 0.0005%

MEI Methode Electronics Inc 175.7819 K 20.7780 K 0.0005%

NEWT NewtekOne Inc 175.0882 K 14.2580 K 0.0005%

DSGR Distribution Solutions Group Inc 173.6891 K 5 809.0000 0.0004%

QTRX Quanterix Corp 171.2628 K 26.1470 K 0.0004%

ATLC Atlanticus Holdings Corp 171.0014 K 3 269.0000 0.0004%

NGVC Natural Grocers by Vitamin Cottage Inc 170.0728 K 6 292.0000 0.0004%

SWIM Latham Group Inc 169.5684 K 25.2710 K 0.0004%

FRPH FRP Holdings Inc 169.4473 K 7 078.0000 0.0004%

ANGI Angi Inc 168.4837 K 21.6560 K 0.0004%

PTRN Pattern Group Inc 168.4063 K 15.9930 K 0.0004%

Nouvelles

SCHB: SCHB: A Hold Amid Premium Valuations And Higher Risk-Free Rates (NYSEARCA:SCHB)

Large Caps - Big Opportunity

3 Reasons Why I Remain Bullish On SCHB, And 2 To Sell It Immediately (NYSEARCA:SCHB)

Q1 2026 Dividend Check-In: Highest Quarterly Hike Percentage Since 2019

Big Tech's $635B AI Push Meets Energy Crunch: ETFs to Diversify

Patience Pays: ETFs You Can Buy and Hold for the Long Run

3 Best ETFs to Invest In, According to AI Analyst, 2/5/2026 - TipRanks.com

SCHB: The Conflict Between Short- And Long-Term Risks (NYSEARCA:SCHB)

ETFs to Keep Your Portfolio on Track in the Long Term

SCHB: Core Equity Holding For Diversified Investors (NYSEARCA:SCHB)

Capital Markets Outlook Q4 2025: Kicking The Can Down The Tightrope

Equity Outlook: From Caution To Complacency?